Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Non Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04049825
What this trial is testing

Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL

Who this might be right for
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Otsuka Pharmaceutical Co., Ltd. 36
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04680052
What this trial is testing

Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Incyte Corporation 654
Large-scale testing (Phase 3)UnknownNCT00003338
What this trial is testing

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Gilead Sciences 60
Testing effectiveness (Phase 2)Study completedNCT03480438
What this trial is testing

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

Who this might be right for
B-Precursor ALL
Goethe University 52
Testing effectiveness (Phase 2)Ended earlyNCT04358458
What this trial is testing

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+5 more
Genmab 46
Testing effectiveness (Phase 2)Study completedNCT00005626
What this trial is testing

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

Who this might be right for
LeukemiaLymphoma
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00004171
What this trial is testing

Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Not applicableStudy completedNCT00985699
What this trial is testing

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 337
Not applicableStudy completedNCT04696692
What this trial is testing

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Institut Claudius Regaud 60
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00080847
What this trial is testing

S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage III Adult Diffuse Large Cell Lymphoma+1 more
National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableStudy completedNCT06392763
What this trial is testing

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

Who this might be right for
Diffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia (ALL)
Novartis Pharmaceuticals 602
Not applicableStudy completedNCT01202448
What this trial is testing

Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Samsung Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT03309878
What this trial is testing

Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Transformed B-Cell Non-Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749976
What this trial is testing

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B Cell Lymphoma (DLBCL)High Risk Myelodysplastic Syndrome+2 more
Vitruviae 108
Testing effectiveness (Phase 2)Ended earlyNCT02253992
What this trial is testing

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Advanced Solid TumorsAdvanced B-cell NHL
Bristol-Myers Squibb 232
Testing effectiveness (Phase 2)UnknownNCT00036426
What this trial is testing

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-Grade
Favrille 22
Next Page